General / Sales FAQ
Nearly all clinical trials suffer from the issue of professional or duplicate research subjects. Upwards of 10% or more of clinical research subjects attempt multiple simultaneous clinical trial enrollment depending on the nature of the clinical trials and the indication. The incidence ranges from 4% to 12% in phase 2 through phase 4 clinical trials depending upon the therapeutic indication. Phase 1 studies have even higher duplicate enrollment or protocol violation attempts. This may result in safety issues and potential risks to the research subject, the site, and sponsor. This can result in poor data quality, research subject safety issues, and increased time and cost to finish a trial and bring a medicine safely to the market. Ultimately, this can result in a clinical trials failure to meet its endpoints. It only takes but a few duplicate subjects or professional research subjects to cause a trial to fail. Furthermore, adverse events arising from combining multiple investigational products by subjects that are not forthcoming about their true study participation may place a possible hold on approval of a study compound, or the need to repeat the entire study. More importantly, this may result in a serious health issue for a volunteer.
There truly is no other company like Verified Clinical Trials.
Verified Clinical Trials is by far the largest most comprehensive research subject database and is the only truly global database operating in over 50 countries, including China. There is no other company or registry that has:
- The largest US and global database for multisite phase II – IV clinical trials
- Dedicated full time customer support across the United States, Europe, and APAC
- Covers the majority of phase 1 units additionally
- Offers optional fingerprint and facial biometric capabilities
- Largest CNS database as well as other therapeutic areas and phase thereby increasing protections
- With VCT’s biometric capabilities, verifications can be performed remotely making the technology available to use in completely decentralized or virtual clinical trials.
It takes less than thirty seconds to verify a subject.
The research coordinator will be able to verify a subject quickly and easily without delaying the screening process. VCT can be accessed from any computer and used by multiple users simultaneously. This results in potential screening of multiple subjects at one time and improving efficiencies. VCT is not cumbersome, nor will it slow down enrollment or the screening process.
VCT is global and is by far the largest research subject clinical trials database registry to prevent duplicate enrollment and many other protocol violations. The VCT network is expansive and is used worldwide in over 50 countries worldwide. Verified Clinical Trials has the largest CNS and psychiatry database of any such registry. VCT also protects multiple other therapeutic indications and covers the phase 1 units too. This is vital as we witness research volunteers crossing over between various phases of clinical trials and other therapeutic indications. This coverage only enhances the overall protections. Our current partners include most of the world’s largest and most significant pharmaceutical corporations as well as small biotechnology companies, the largest and top national and international CROs, and local research centers globally.